Mefenamic Acid
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Cause type: Dissolution failure
The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.
PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules
Failed Dissolution Specifications
Failed USP Dissolution Test Requirements: Out of Specification dissolution result at 18 month time point
Failed Dissolution Specification
Failed Dissolution Specifications.
Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.
Failed Dissolution Specifications: Low out of specification results for dissolution.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.